Merck (BSP:MRCK34) Current Accrued Expense : R$77,250 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Merck Current Accrued Expense?

Merck's Current Accrued Expense for the quarter that ended in Dec. 2023 was R$77,250 Mil.

Merck's quarterly Current Accrued Expense increased from Jun. 2023 (R$66,724 Mil) to Sep. 2023 (R$73,290 Mil) and increased from Sep. 2023 (R$73,290 Mil) to Dec. 2023 (R$77,250 Mil).

Merck's annual Current Accrued Expense declined from Dec. 2021 (R$78,371 Mil) to Dec. 2022 (R$74,270 Mil) but then increased from Dec. 2022 (R$74,270 Mil) to Dec. 2023 (R$77,250 Mil).

Merck Current Accrued Expense Historical Data

The historical data trend for Merck's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Current Accrued Expense Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

51,507.37

62,827.08

78,371.26

74,269.62

77,250.25

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															67,711.80	66,723.81	73,290.31	77,250.25	-

Merck Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Merck Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Merck's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BSP:MRCK34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSP:MRCK34) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (BSP:MRCK34) Headlines

No Headlines